Few industries carry higher stakes for decision-making than healthcare. Whether you are developing a new therapy, launching a consumer health brand, or redesigning the customer experience for a hospital network, the cost of acting on flawed assumptions is measured in more than revenue -- it affects patient outcomes, regulatory standing, and public trust. Yet the complexity of the health ecosystem means that standard market research methods often fall short. Payer dynamics, clinical workflows, regulatory constraints, and rapidly shifting consumer attitudes demand a specialized research approach.
Meraki Research delivers healthcare market research that accounts for this complexity. We work with pharmaceutical companies, medical device manufacturers, health systems, digital health ventures, and consumer wellness brands to provide the market understanding they need to make confident strategic decisions. Our team brings deep domain expertise in both the clinical and commercial sides of health and wellbeing, so our research captures the perspectives that matter most -- from prescribers and payers to patients and caregivers.
Our healthcare practise has supported product launches, brand development & strategy, pricing optimisation, and customer experience transformation across the health sector. We combine rigorous methodology with practical, business-focused deliverables that move from insight to action -- because in healthcare, the distance between research and impact needs to be as short as possible.
The Research Challenges Unique to Healthcare
Healthcare research is not simply "market research applied to hospitals." Several structural factors make it fundamentally distinct, and any firm that ignores them produces research that fails at the point of application:
- Regulated respondents. Physicians, pharmacists, and nurses operate under time pressure and compliance constraints. Reaching them -- and earning candid responses -- requires specialized recruiting and moderation techniques that generic research firms do not possess.
- Multi-stakeholder decisions. A single purchasing decision in a hospital may involve clinical staff, procurement, IT, compliance, and the C-suite. Understanding the full decision architecture is essential for any research that aims to inform commercial strategy.
- Payer influence. Insurance coverage, formulary placement, and reimbursement dynamics shape market access in ways that do not exist in most industries. Research that ignores the payer perspective provides an incomplete picture of your true market opportunity.
- Rapid regulatory change. FDA guidance, CMS policy shifts, and state-level regulations can reshape a market in months. Research designs must be current with the regulatory environment, and findings must be interpreted in that context.
- Emotional and ethical weight. Healthcare decisions affect patient lives. Research with patients and caregivers requires ethical sensitivity, informed consent, and methodological rigor that goes beyond standard market research practice.
Our methodology is built to address each of these challenges head-on.
Our Approach: Meraki Health Insights Methodology
We designed our healthcare research practise around the principle that good health market research must be as rigorous as the clinical environment it studies. Every engagement follows a structured process with built-in flexibility for the specific regulatory and stakeholder landscape of your category.
Phase 1 -- Landscape and Stakeholder Mapping
We begin with a comprehensive review of the therapeutic area, category, or service line under investigation. This includes secondary research on market size, competitive dynamics, regulatory environment, and payer landscape. We also map the full stakeholder ecosystem -- identifying which audiences (HCPs, patients, payers, administrators, caregivers) need to be included in the primary research and what role each plays in the decision process.
For pharma and device engagements, this phase includes a review of published clinical evidence, treatment guidelines, and formulary status. For consumer brands in health and wellbeing, we analyse retail dynamics, competitive positioning, and consumer sentiment. The goal is the same in every case: build a foundation of market understanding that ensures our primary research asks the right questions of the right people.
This phase delivers a clear research brief and sampling plan that accounts for the unique recruitment challenges of healthcare audiences.
Phase 2 -- Primary Data Collection
Our fieldwork draws on methods tailored to healthcare respondents:
- Physician depth interviews and advisory boards conducted by moderators with clinical literacy who can engage HCPs at their level. Our moderators understand treatment algorithms, formulary mechanics, and the realities of clinical practice -- which means physicians give us substantive answers instead of surface-level responses.
- Patient and caregiver research designed with IRB-level sensitivity to privacy, informed consent, and emotional burden. We use trauma-informed interview techniques for conditions with high emotional weight, and we recruit beyond convenience samples to ensure diverse representation.
- Payer and formulary research that captures decision frameworks for coverage, tier placement, and usage criteria. We speak directly to pharmacy directors, medical directors, and health economists at plans and PBMs.
- Quantitative surveys using medically validated scales where appropriate, with panel sources that deliver verified HCP and patient samples. Every respondent is screened against NPI databases or equivalent verification.
We invest heavily in recruitment quality. In healthcare, a poorly screened sample does not just reduce accuracy -- it can lead to strategic decisions that fail at launch. Our average screener rejection rate in healthcare studies exceeds 35%, which reflects the rigor of our qualification process.
Phase 3 -- Usage and Attitudes Analysis
For product and brand-focused engagements, we deploy our structured usage and attitudes framework. This captures current prescribing or purchasing behaviour, brand perception, unmet needs, and switching triggers. We benchmark your performance against competitors and identify the attitudinal segments most likely to adopt, switch, or advocate.
This analysis is especially valuable for consumer brands in the OTC, supplement, and wellness categories where attitudes toward health and wellbeing drive purchasing as much as clinical evidence. We segment audiences not just by demographics but by their relationship to health -- their beliefs, their information sources, their trust in different types of evidence, and their willingness to try new products.
The usage and attitudes framework also supports share-of-wallets analysis, helping you understand how your product competes for healthcare spending against alternatives, substitutes, and do-nothing inertia.
Phase 4 -- Communication Effectiveness Testing
When your engagement involves messaging, creative, or campaign evaluation, we integrate communication effectiveness testing directly into the research design. We evaluate how target audiences respond to claims, visuals, and positioning -- measuring comprehension, credibility, emotional resonance, and behavioral intent.
For regulated categories, our testing protocols account for fair-balance requirements and the specific communication constraints of pharma and device marketing. We design stimuli and evaluation frameworks that produce findings your medical-legal-regulatory team can act on, not just your creative team.
This phase is particularly valuable during pre-launch message development, DTC campaign planning, and HCP promotional material refinement.
Phase 5 -- Synthesis, Optimisation, and Strategic Recommendations
We do not deliver data dumps. Our final phase synthesizes findings into a strategic narrative that answers your core business questions. We identify the highest-impact opportunities for growth, the performance gaps to close, and the optimisation priorities for your go-to-market strategy.
Every recommendation is grounded in the research evidence and pressure-tested against commercial feasibility. We present findings in a format designed for executive decision-making -- clear, concise, and structured around the actions your team needs to take, not the methodology we used to get there.
When Healthcare & Pharma Market Research Applies
Our healthcare practise is designed for organizations that need research expertise at the intersection of clinical, commercial, and consumer dynamics. Common triggers include:
- Pre-launch planning for a new therapy, device, or health service requiring market sizing, segmentation, and positioning research.
- Brand development & strategy for established or emerging health brands seeking to sharpen differentiation and strengthen competitive positioning.
- Customer experience transformation for health systems, payers, or digital health platforms looking to improve patient or member satisfaction.
- Portfolio prioritization requiring market understanding across multiple therapeutic areas or service lines.
- Market access and pricing research for products navigating complex payer and formulary landscapes.
- Communication effectiveness evaluation for promotional campaigns, patient education, or HCP engagement programs.
When it is NOT the right fit: If your research need is entirely outside of health and wellbeing -- for example, pure B2B technology or financial services -- our general market research or primary research capabilities are a better starting point. We also do not conduct clinical trials or outcomes research; our work sits on the commercial and strategic side of the health enterprise.
What We Deliver
| Deliverable | Format | Description |
|---|---|---|
| Market Landscape Report | 50-80 page document | Category dynamics, competitive mapping, market understanding, and opportunity sizing |
| Usage & Attitudes Study | Report + data tables | Behavioral segmentation, brand performance benchmarking, and switching analysis |
| Communication Effectiveness Report | Presentation + statistical appendix | Message and creative evaluation with optimisation recommendations |
| Stakeholder Journey Maps | Visual deliverable | Decision-process maps for HCPs, patients, payers, or administrators |
| Strategic Recommendations Deck | Executive presentation | Prioritized actions with business-case support for leadership |
Timeline: Healthcare engagements typically run 10-14 weeks given the specialized recruitment requirements. Engagements scoped to a single audience (e.g., physicians only) can often be completed in 8 weeks. Multi-market international studies may extend to 16-18 weeks.
Industry Applications
- Pharmaceutical & Biotech -- Launch readiness, prescriber segmentation, formulary access strategy, and brand development & strategy for both branded and generic portfolios.
- Medical Devices & Diagnostics -- Procedural adoption research, surgeon and hospital-administrator attitudes, and competitive positioning for surgical, diagnostic, and monitoring technologies.
- Consumer Health & Wellness -- Usage and attitudes research for OTC medications, supplements, personal care, and wellbeing products where consumer brands compete on trust and efficacy.
- Digital Health & Health Tech -- User adoption, customer experience research, and market sizing for telehealth, remote monitoring, and health data platforms.
- Health Systems & Payers -- Patient experience, service line performance evaluation, and network optimisation research for hospitals, insurers, and integrated delivery networks.
- Retail Health & Pharmacy -- Shopper insights, retail strategy, and share-of-wallets analysis for pharmacy chains and retail health clinics navigating the shift toward consumer-directed care.